Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Receivables - Other: 2012-2015

Historic Receivables - Other for Enanta Pharmaceuticals (ENTA) over the last 4 years, with Sep 2015 value amounting to $433,000.

  • Enanta Pharmaceuticals' Receivables - Other fell 46.39% to $1.0 million in Q4 2015 from the same period last year, while for Dec 2015 it was $1.0 million, marking a year-over-year decrease of 46.39%. This contributed to the annual value of $433,000 for FY2015, which is 84.37% down from last year.
  • Enanta Pharmaceuticals' Receivables - Other amounted to $433,000 in FY2015, which was down 84.37% from $2.8 million recorded in FY2014.
  • Over the past 5 years, Enanta Pharmaceuticals' Receivables - Other peaked at $2.8 million during FY2014, and registered a low of $433,000 during FY2015.
  • Moreover, its 3-year median value for Receivables - Other was $784,000 (2013), whereas its average is $1.3 million.
  • As far as peak fluctuations go, Enanta Pharmaceuticals' Receivables - Other soared by 253.32% in 2014, and later crashed by 84.37% in 2015.
  • Enanta Pharmaceuticals' Receivables - Other (Yearly) stood at $1.7 million in 2012, then crashed by 53.00% to $784,000 in 2013, then spiked by 253.32% to $2.8 million in 2014, then slumped by 84.37% to $433,000 in 2015.